SPECIFIC TERMS IN THIS EXHIBIT HAVE BEEN REDACTED. THESE REDACTED TERMS HAVE BEEN MARKED IN THIS EXHIBIT WITH THREE ASTERISKS [***].Shareholders’ Rights Agreement • September 5th, 2023 • Fortress Investment Group LLC • Investment advice
Contract Type FiledSeptember 5th, 2023 Company IndustryTHIS AMENDED AND RESTATED SHAREHOLDERS’ RIGHTS AGREEMENT (this “Agreement”) is made as of September 4, 2023, by and among CFIP CLYD (UK) Limited, a U.K. private limited company (“UKF”), and Celyad Oncology SA, a limited liability company incorporated and existing in the form of a naamloze vennootschap / société anonyme under Belgian law, having its registered office at Rue Edouard Belin 2, 1435 Mont-Saint-Guibert (Belgium) and registered with the Crossroads Bank for Enterprises under number 0891.118.115 (RLE Brabant Wallon) (the “Company”).
FORM OF AMENDED AND RESTATED SHAREHOLDERS’ RIGHTS AGREEMENT BY AND AMONG CFIP CLYD LLC, CFIP CLYD (UK) LIMITED AND CELYAD ONCOLOGY SA Dated as of , 2023Shareholders’ Rights Agreement • August 24th, 2023 • Fortress Investment Group LLC • Investment advice • New York
Contract Type FiledAugust 24th, 2023 Company Industry JurisdictionTHIS AMENDED AND RESTATED SHAREHOLDERS’ RIGHTS AGREEMENT (this “Agreement”) is made as of , 2023, by and among CFIP CLYD LLC, a Delaware limited liability company (“CFIP”), CFIP CLYD (UK) Limited, a U.K. private limited company (“UKF”), and Celyad Oncology SA, a limited liability company incorporated and existing in the form of a naamloze vennootschap / société anonyme under Belgian law, having its registered office at Rue Edouard Belin 2, 1435 Mont-Saint-Guibert (Belgium) and registered with the Crossroads Bank for Enterprises under number 0891.118.115 (RLE Brabant Wallon) (the “Company”).